Sign inJoin waitlistJoin the waitlist

Joseph Mikhael

Physician · HonorHealth

Credentials: · ·

History

HonorHealth
Present

Hematology and Medical Oncology
2000–2003
Internal Medicine
1997–2000
Doctor of Medicine
1993–1997

Research

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013
Mayo Clinic Proceedings · 2013 · First of 29 authors · Corresponding · 428 citations
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Blood · 2017 · 428 citations
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Review · The Lancet Oncology · 2017 · 425 citations

Shaji Kumar
48 papers
AS
Alexander Stewart
38 papers
CR
Craig Reeder
38 papers
Rafael Fonseca
37 papers
SR
Sundararajan Rajkumar
35 papers
Angela Dispenzieri
34 papers
Leif Bergsagel
33 papers
ML
Martha Lacy
33 papers
Morie Gertz
29 papers
David Dingli
27 papers
Francis Buadi
27 papers
Suzanne Hayman
26 papers

Clinical trials

Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Principal investigator · Completed · Phase 1, Phase 2
Mayo Clinic
2011–2018
Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant
Principal investigator · Completed · Phase 2
Mayo Clinic
2009–2015
Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma
Study chair · Completed · Phase 1, Phase 2
Mayo Clinic
2010–2017
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Study chair · Terminated · Phase 1, Phase 2
PrECOG, LLC.
2009–2018